APP at the Heart of Change: Evolving Cardiovascular Care

Friday, April 10, 2026, 7:00 AM - 3:30 PM PT, Cedars-Sinai Harvey Morse Conference Center, Los Angeles, CA


The 2026 APP at the Heart of Change: Evolving Cardiovascular Care Symposium will provide basic and advanced knowledge of various guideline-based medical therapies in the management and care coordination of patients with cardiovascular illness and disorders. The latest guidelines and therapies will emphasize competency based practice towards excellence in clinical skills, value-based, patient-centered, and deliver culturally competent care. Each section will enable opportunities to acquire skills required to use and monitor advanced noninvasive cardiovascular devices and promote the translation of AHP-led care delivery models and best practices in cardiovascular team practice settings. The symposium will integrate principles of population health management in primary and secondary prevention of cardiovascular illnesses and related comorbidities.

1. Review advanced EKG patterns and apply key interpretation pearls to improve clinical decision making and patient care
2. Review the latest advances in cardiovascular health management for women
3. Describe current best practices in the diagnosis and treatment of cardiac amyloidosis
4. Summarize emerging research and clinical updates in transcatheter tricuspid and mitral valve replacement technologies
5. Examine diagnostic capabilities of consumer wearables, innovations in cardiac implantable electronic devices, and upcoming developments in atrial fibrillation ablation
6. Evaluate the evidence supporting GLP1 receptor agonists and apply appropriate patient selection, prescribing considerations, and monitoring strategies to reduce cardiometabolic risk
7. Discuss the complexities of congenital heart disease in adult patients
8. Explore vascular diseases with a focus on emerging risk factors, evolving diagnostic tools, and contemporary treatment approaches
9. Review current strategies for managing pulmonary hypertension and understand its clinical impact
10. Highlight APP led care models that are transforming cardiovascular healthcare delivery
11. Collaborate across disciplines to apply evidence based cardiovascular care, coordinate complex pathways, and optimize patient centered outcomes.

In-Person Fee
Cedars-Sinai Employees & Affiliates Healthcare Professional (In-Person) - $0.00
Non-Cedars Healthcare Professional (In-Person) - $25.00
Student (In-Person) - $0.00

Virtual Fee
Cedars-Sinai Employees & Affiliates Healthcare Professional (Virtual) - $0.00
Non-Cedars Healthcare Professional (Virtual) - $25.00
Student (Virtual) - $0.00

In support of improving patient care, Cedars-Sinai is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

ANCC Credit for Nurses:  This activity is approved for 6.25 ANCC contact hours.

AAPA Credit for Physician Assistants: Cedars-Sinai has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.25  AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Interprofessional Continuing Education: This activity was planned by and for the healthcare team and learners will receive 6.25 Interprofessional Continuing Education (IPCE) credit(s) for learning and change.

AAPA Category 1 CME credit (6.25 hours), ANCC (6.25 hours), IPCE (6.25 hours)

Mitigation of Relevant Financial Relationships

Cedars-Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Friday, April 10, 2026